NIH-funded research R01 grant

How primary progressive aphasia changes language, thinking, and the brain over time

Official title: Primary Progressive Aphasia: Cognition, Anatomy and Progression

Funded at University of California, San Francisco · NIH-10795771 · Data updated 2026-11-12

Following people with primary progressive aphasia to track changes in speech, thinking, brain scans, and biological markers over time.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startJuly 15, 2004
Project endAugust 31, 2027
Funding year2025
Award (this year)$1,472,629
NIH project number4R01NS050915-19
Project IDNIH-10795771 on NIH RePORTER

Who could benefit from this research

Could help

People diagnosed with primary progressive aphasia or with progressive, language-predominant decline—particularly those in early to mid stages—are the ideal candidates.

Less likely to help

People whose symptoms are not primarily language-related, or those unwilling to undergo brain imaging or provide biological samples, are unlikely to benefit directly from participation.

What this research studies

You would join a long-running program that has evaluated over 400 people with primary progressive aphasia. You would have detailed speech and language testing, cognitive exams for thinking and visuospatial skills, structural and functional MRI scans, and usually blood or other biomarker and genetic testing; brain donation for pathology is included in some cases. The team uses these combined clinical, imaging, biomarker, and pathological data to better define how different diseases cause PPA and why certain brain networks are vulnerable. Their goal is to create objective clinical outcome tools and clarify the heterogeneity that can make diagnosis and trial inclusion difficult.

Why it matters

Potential benefit: If successful, this work could produce clearer diagnostic markers and objective outcome measures to help include more people with PPA in clinical trials and guide better, earlier care.

How similar studies have gone: Related long-term PPA and biomarker cohorts have already led to international diagnostic criteria and many publications, but objective outcome tools for trials remain an unmet need that this project aims to address.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Gorno Tempini, Maria Luisa — University of California, San Francisco
  • Study coordinator: Gorno Tempini, Maria Luisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.